Home › MolMed TK therapy submitted for Conditional Marketing Authorisation in EU
 

Keywords :   


MolMed TK therapy submitted for Conditional Marketing Authorisation in EU

2014-03-13 21:03:04| Logistics - Topix.net

MolMed S.p.A. announces that the Company has filed to the European Medicines Agency an application for Conditional Marketing Authorisation for TK, its novel investigational cell-gene therapy.

Tags: in marketing submitted therapy

Category:Transportation and Logistics

Latest from this category

All news
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Tropical Depression Eighteen Graphics
04.11Remnants of Patty Graphics
04.11Remnants of Patty Forecast Discussion Number 10
Transportation and Logistics »
04.11Tropical Depression Eighteen Graphics
04.11Tropical Depression Eighteen Public Advisory Number 4A
04.11Remnants of Patty Graphics
04.11Atlantic Tropical Weather Outlook
04.11Eastern North Pacific Tropical Weather Outlook
04.11Paper Excellence Group Rebrands as Domtar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
More »